메뉴 건너뛰기




Volumn 7, Issue 2, 2012, Pages 139-141

The king is dead (warfarin): Direct thrombin and factor Xa inhibitors: The next Diadochian War?

Author keywords

Antithrombotic; Cerebral hemorrhage; Cerebral infarction; Clinical trial; Ischemic stroke; Stroke

Indexed keywords

ANTIVITAMIN K; APIXABAN; DABIGATRAN; KETOCONAZOLE; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; RIVAROXABAN; WARFARIN;

EID: 84856199694     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00739.x     Document Type: Article
Times cited : (8)

References (7)
  • 1
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146 : 857-867.
    • (2007) Ann Intern Med , vol.146 , pp. 857-867
    • Hart, R.G.1    Pearce, L.A.2    Aguilar, M.I.3
  • 2
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • Granger CB, Alexander JH, McMurray JJ etal. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365 : 981-992.
    • (2011) N Engl J Med , vol.365 , pp. 981-992
    • Granger, C.B.1    Alexander, J.H.2    McMurray, J.J.3
  • 3
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly SJ, Ezekowitz MD, Yusuf S etal. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361 : 1139-1151.
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 4
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • Patel MR, Mahaffey KW, Garg J etal. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365 : 883-891.
    • (2011) N Engl J Med , vol.365 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3
  • 5
    • 78751637313 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion
    • Nagarakanti R, Ezekowitz MD, Oldgren J etal. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion. Circulation 2011; 123 : 131-136.
    • (2011) Circulation , vol.123 , pp. 131-136
    • Nagarakanti, R.1    Ezekowitz, M.D.2    Oldgren, J.3
  • 6
    • 77952167209 scopus 로고    scopus 로고
    • Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor
    • Stangier J, Clemens A. Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor. Clin Appl Thromb Hemost 2009; 15(Suppl. 1):9S-16S.
    • (2009) Clin Appl Thromb Hemost , vol.15 , Issue.SUPPL. 1
    • Stangier, J.1    Clemens, A.2
  • 7
    • 68549085236 scopus 로고    scopus 로고
    • Factor Xa inhibitors - new anticoagulants for secondary haemostasis
    • Perzborn E. Factor Xa inhibitors - new anticoagulants for secondary haemostasis. Hamostaseologie 2009; 29 : 260-267.
    • (2009) Hamostaseologie , vol.29 , pp. 260-267
    • Perzborn, E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.